Skip to content

Pilot Study of PACHA Program to Enhance Adherence to Adjuvant Endocrine Therapy Among Breast Cancer Survivors

Breast Cancer | Breast Neoplasms

The goal of this randomized controlled pilot study is to assess the feasibility, acceptability, and preliminary effects of the PACHA program designed for women having an adjuvant endocrine therapy (AET) after hormone-sensitive breast cancer. PACHA (programme en Pharmacie pour l'ACcompagnement des femmes ayant de l'Hormonothérapie Adjuvante) is a community pharmacy-based program aimed at optimizing the experience of AET and its use. The main questions it aims to answer are :

* Does the program have an effect on factors expected to influence AET adherence?
* Is the program acceptable?
* Is the implementation of the program feasible?
* What is the feasibility of procedures for carrying out a full-scale study?

Participating community pharmacies will be randomized. Pharmacists working in pharmacies assigned to the PACHA group (33 pharmacies) will receive web-based training and manuals to use during their consultations with women having an AET. Recruited women attending these pharmacies will also have access to information and resources about AET (videos, evidence-based booklet). Pharmacists practicing in pharmacies assigned to the control group (33 pharmacies) will provide usual care.

null

Conditions de participation

  • Sexe:

    ALL

  • Âges admissibles:

    18 and up

Critères de participation

Inclusion Criteria:

For pharmacies :

* In the province of Quebec, Canada
* At least one pharmacist agrees to take charge of the project in their pharmacy
* At least one women has initiated adjuvant endocrine therapy (AET) in the last 6 months in the pharmacy

For pharmacists :

* Practicing in a pharmacy in the province of Quebec
* Provide consent

For women :

* 18 years old or older
* Were diagnosed with a first non-metastatic, hormone-sensitive breast cancer
* Received and AET prescription for the first time in the last 6 months
* Are fluent in French
* Have internet access
* Provide consent

Exclusion Criteria:

For women :

• Live in a residential facility where AET is not self-managed

Lieu de l'étude

Centre de recherche du CHU de Québec
Centre de recherche du CHU de Québec
Quebec city, Quebec
Canada

Contactez l'équipe d'étude

Primary Contact

Julie Lapointe, Ph.D.

[email protected]
418-682-7511
Étude parrainée par
CHU de Quebec-Universite Laval
Participants recherchés
Plus d'informations
ID de l'étude: NCT05887102